Compound details
Haedoxan A
| Compound ID | CDAMM01519 |
|---|---|
| Common name | Haedoxan A | IUPAC name | 6-[3-(1,3-benzodioxol-5-yl)-6-methoxy-2-(methoxymethyl)-2,3-dihydro-1,4-benzodioxin-7-yl]-3-[(4,6-dimethoxy-1,3-benzodioxol-5-yl)oxy]-3,4,6,6a-tetrahydro-1H-furo[3,4-c]furan-3a-ol |
| Molecular formula | C33H34O14 |
| Retention time | 7.53 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 655.201 | Theoretical mz | 655.202 |
| Error | 2.1 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.2642 |
| Inchi key | SVQIUEXUTJVJTM-UBUOSFEXNA-N |
|---|---|
| Smiles | OC12COC(C=3C=C4OC(COC)C(OC4=CC3OC)C5=CC=C6OCOC6=C5)C2COC1OC7=C(OC)C=C8OCOC8=C7OC |
| Superclass | Organoheterocyclic compounds |
| Class | Benzodioxanes |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |